4.19. Analysis.
Comparison 4 Rivastigmine 10 cm2 patch (9.5 mg/day) versus placebo, Outcome 19 at least one adverse event of nasopharyngitis by 24 weeks.
Comparison 4 Rivastigmine 10 cm2 patch (9.5 mg/day) versus placebo, Outcome 19 at least one adverse event of nasopharyngitis by 24 weeks.